We examined dengue virus immune complex-phagocyte interaction with respect to a single Fc receptor class using a transient expression system involving the high-affinity human macrophage receptor, Fc␥RI. We found that New Guinea C strain dengue 2 virus formed well-defined plaques in normal and transfected COS cells and we analyzed the structural determinants of Fc␥RI-mediated binding and internalization of dengue 2 virus immune complexes by expressing native or truncated forms of the receptor in COS cells, alone or with its accessory ␥ chain signaling unit, which bears an immunoreceptor tyrosine-based activation motif (ITAM). The residual infectivity of dengue 2 virus treated with neutralizing human antiserum was strikingly higher in Fc␥RI-bearing COS cells than in controls. Compatible with the IgG subclass specificity of Fc␥RI, this difference was abrogated quantitatively by treatment of Fc␥RI-transfected cells with human IgG1 but not IgG2 myeloma protein. The magnitude of receptor-mediated plaque formation after cotransfection with ␥ chain was also significantly higher than in controls but was less than that observed with Fc␥RI transfection only, a difference probably explained by reduced levels of Fc␥RI expression in ␥ chain cotransfectants. Deletion of the Fc␥RI cytoplasmic domain had no effect on receptor-mediated immune complex infectivity. We conclude that the Fc␥RI extracellular domain is sufficient for internalization of infectious dengue virus immune complexes through a mechanism that does not involve classical ITAMdependent signaling.
INTRODUCTION
Antibody-complexed virus may escape neutralization by preferentially infecting macrophages after Fc receptor (FcR) attachment. This in vitro phenomenon underlies older observations of increased residual infectivity (Kjellen and Schlesinger, 1959) and paradoxically enhanced viral replication (Hawkes, 1964) when partially neutralized vesicular stomatitis virus or several flaviviruses were titrated in primary chick embryo fibroblast monolayers. Enhanced virus plaque formation in these cultures was subsequently explained when they were found to harbor functional macrophages (Kliks and Halstead, 1980) . Immune enhancement has since been observed with a number of disparate RNA and DNA viruses grown in cultured mammalian macrophages in the presence of anti-viral antibodies (reviewed in Dimmock, 1993) . Despite its apparent ubiquity, immune enhancement remains enigmatic; its molecular basis, like that of neutralization itself, is incompletely understood and its biologic significance is poorly defined. Among viruses whose growth in macrophages can be amplified by antivirion antibody, dengue virus, an enveloped positivesense RNA flavivirus, has received considerable attention because of persuasive seroepidemiologic evidence linking immune status of the dengue virus-infected individual to risk of life-threatening complications; FcR-bearing cells of macrophage/monocyte lineage are believed to be the primary if not exclusive site of replication in the course of human dengue virus infection (reviewed in Halstead, 1988) .
Previous in vitro studies of antibody-mediated viral replication in macrophages have exclusively employed cultured cells that simultaneously express multiple FcR classes and isoforms of differing physiology. Such heterogeneity together with evidence of cooperative interactions among FcRs of differing classes (reviewed in Hulett and Hogarth, 1994; Daeron, 1997) presents obvious complexities in the interpretation of experimental results. To examine the nature of dengue virus immune complex-FcR interaction and its consequences with respect to a single receptor class, we have adopted a transient expression system in COS-7 fibroblasts involving human Fc␥RI (Allen and Seed, 1989; Ernst et al., 1992) , one of three classes of macrophage receptors for IgG. Fc␥RI exists as a 72-kDa integral membrane glycoprotein composed of three domains: extracellular Fc piece-binding, short transmembrane, and cytoplasmic "tail." It is distinguished from other Fc receptors by its high affinity for both monomeric and complexed IgG and by in vivo evidence that it enhances antigen presentation and augments antigen-specific antibody responses in Fc␥RI transgenic mice (Heijnen et al., 1996) . The transmembrane portion of Fc␥RI associates with a short (22 kDa) homodimeric transmembrane subunit, the ␥ chain, which confers signal transduction capacity by providing an immunoreceptor tyrosine-based activation motif (ITAM) that Fc␥RI lacks (Allen and Seed, 1989) . The ␥ chain subunit enhances affinity for ligand (Miller et al., 1996) and is necessary for efficient Fc␥RI-mediated phagocytosis of opsonized large particles (Davis et al., 1995; Lowry et al., 1998) , a process that requires protein tyrosine kinase-catalyzed ITAM phosphorylation. The Fc␥RI extracellular domain alone, expressed in COS cells, has been reported to be sufficient for pseudopod extension (Lowry et al., 1998) , for endocytosis of Fc␥RI-bound radiolabeled IgG, and for Fc␥RI entry into an internalization-recycling pathway after IgG binding (Harrison et al., 1994; Davis et al., 1995) . COS cells that express Fc␥RI, properly configured with its accessory ␥ chain, thus exhibit important characteristics of professional phagocytes with respect to FcR-mediated antigen uptake and metabolic consequences of immune complex-stimulated Fc␥RI clustering. Additionally, as described herein, they offer a convenient system to examine FcR-dengue immune complex interaction, since we have found that dengue virus type 2 (New Guinea C strain) forms well-defined plaques in Fc␥RI-transfected COS cell monolayers, a property of dengue virus not present in cultured macrophages or macrophage-like cell lines (Peiris and Porterfield, 1981; J. J. Schlesinger, unpublished results) . In the present study, we analyzed structural determinants of Fc␥RI-mediated binding and internalization of dengue 2 virus immune complexes by expressing native or truncated forms of the receptor in COS cells, alone or in association with the ␥ chain signaling unit.
RESULTS AND DISCUSSION
The residual infectivity of partially neutralized dengue 2 virus is increased in Fc␥RI-transfected COS cells 6 PFU/ml New Guinea C strain dengue 2 virus and two dilutions (final 1/2500 and 1/5000) of pooled human anti-dengue virus serum and were mixed with increasing concentrations of a human IgG1 myeloma protein before addition to Fc␥RI-transfected (FcR) or mock-transfected (M) COS cells. A human IgG2 myeloma protein and human serum albumin (hu sa) at a comparable high concentration were used as controls. These results are representative of four independent experiments examining specificity of antibody-complexed dengue 2 virus binding to human Fc␥RI. 24-well cluster plate for plaque assay. The antiserum exhibited potent neutralizing activity that was unaffected by myeloma protein in control COS cells. Residual infectivity of virus-antibody complexes was considerably increased (Ͼ100-fold) in Fc␥RI-transfected cells and, consistent with the relative affinities for Fc␥RI, receptor blockade with high concentrations of IgG1, but not IgG2, myeloma abrogated this effect. These findings indicate that cell surface Fc␥RI subserves dengue virus immune complex infectivity in COS cells and that Fc␥RI-mediated internalization of virus-antibody complexes is independent of protein tyrosine kinase-based signaling.
The ␥ chain subunit does not augment Fc␥RI-mediated internalization of infectious dengue 2 virus immune complexes Although Fc␥RI was sufficient for internalization of infectious dengue 2 immune complexes, the ␥ chain's capacity to markedly increase this receptor's affinity for ligand (Miller et al., 1996) and uncertainty concerning a possible synergistic ITAM effect on internalization of antibody-complexed virus prompted us to test whether cotransfection with Fc␥RI and the ITAM-bearing ␥ chain subunit affected dengue immune complex infectivity. COS cells, transfected with Fc␥RI and ␥ chain individually or in combination, were exposed to preformed virus immune complexes. In parallel assays we used antibody-sensitized sheep red blood cells to measure rosetting and phagocytosis as confirmation of Fc␥RI and Fc␥RI/␥ chain coexpression, respectively. Since cotransfection with ␥ chain has been shown to reduce total Fc␥RI concentration circa threefold, as measured by Scatchard analysis (Miller et al., 1996) , we varied the cDNA transfectant ratios but found no significant differences in residual infectious virus titers or in rosetting or phagocytosis indices among several Fc␥RI:␥ chain ratios (see Materials and Methods). Therefore, these data were pooled. A total of nine experiments were performed using a fixed amount of virus (1 ϫ 10 6 PFU) treated with two dilutions of partially neutralizing antiserum. Although plaque counts varied considerably and unpredictably from one experiment to another, a consistent pattern of increased residual infectivity, statistically significant at both antiserum dilutions, was observed with Fc␥RI and Fc␥RI/␥ chain-expressing cells compared to control cells (Table 1A) . As expected, serum neutralizing activity was unaffected in ␥ chain transfectants. Interestingly, cotransfection was associated with a consistent, approximately twofold reduction in immune complex infectivity at both antiserum dilutions (1/800, P Ͻ 0.02; 1/1600, P Ͻ 0.001) compared to that found with cells expressing Fc␥RI only. We postulate that this difference is explained by the previously demonstrated several-fold reduction in Fc␥RI density that attends ␥ chain cotransfection (Miller et al., 1996) , although we cannot rule out an unrelated "down-regulating" effect of the ␥ chain on Fc␥RI-mediated viral entry or subsequent replication events.
The extracellular Fc␥RI domain is sufficient to augment internalization of infectious dengue 2 virus immune complexes
Finally, we analyzed whether deletion of the Fc␥RI cytoplasmic domain (tail) affects infectious immune complex internalization by comparing results with COS cells expressing native and truncated forms of the receptor. The function of the Fc␥RI tail has not been well defined. Its removal is associated with a slight increase in binding affinity of the truncated form (Miller et al., 1996) and limited data suggest that a tailless Fc␥RI construct subserves endocytosis, at least as measured by Fc␥RI internalization after receptor cross-linking by antibody (Davis et al., 1995) . However, it is uncertain whether mechanisms of endocytosis involving FcR aggregated by IgG cross-linkage are the same as those that govern FcR-mediated internalization of infectious antibody-complexed virus. Table 1B shows results of four experiments performed in duplicate that demonstrate essentially equivalent mediation of immune complex infectivity by native Fc␥RI and mutant Fc␥RI tailless-transfected COS cells after exposure to preformed dengue immune complexes. Molecular dissection of Fc␥RI biology indicates that phagocytosis (internalization of large opsonized particles) and endocytosis (internalization of soluble immune complexes) are biologically distinguishable. In both processes ligand-clustered Fc␥RI is internalized, but only for efficient phagocytosis are protein tyrosine kinase activation and ITAM phosphorylation essential. Taken together, our results with an opsonized virus are compatible with and extend earlier work of Davis et al. (1995) , who showed ITAM-independent Fc␥RI internalization (endocytosis) after IgG cross-linking, and of Mady et al. (1991) , whose findings with bispecific antibodies against cell membrane-associated proteins other than FcR on human macrophage-like U937 cells suggested that FcR attachment of dengue immune complexes facilitated infectivity by "focusing" virus onto the cell surface. It remains unknown whether a specific virus receptor acts in concert with Fc␥RI to effect internalization of infectious antibodycomplexed dengue virus; whether Fc␥RI accompanies, and if so, directs the complexes on their probable journey to lysosomes; or if, in vivo, dengue virus immune complex-induced Fc␥RI clustering (that likely includes coaggregation of other FcR classes) might coincidentally activate ITAM-dependent pathways of immunopathologic importance.
MATERIALS AND METHODS

Cells and viruses
COS-7 cells (obtained from Dr. Clark Anderson, Ohio State University, Columbus, OH), maintained in D-MEM supplemented with 10% fetal bovine serum, were plated at a density of ca. 1-2 ϫ 10 6 cells in 60-or 100-mm plastic petri dishes and transfected the next day when monolayers were ca. 80% confluent. C6/36 Aedes albopictus mosquito cells, grown at 28°C in MEM supplemented with 5% fetal bovine serum, were used to propagate New Guinea C strain dengue 2 virus, obtained in suckling mouse brain from Dr. Walter E. Brandt (Walter Reed Army Institute of Research, Washington, DC). Virus was titered by plaque assay in COS and Vero cells: plating efficiency was equivalent in both cell types.
Plasmid constructs and transfections
The human Fc␥RI (isoform A) cDNA and its tailless mutant (missing 61 amino acids from the protein's cterminus), each cloned into the pCDM vector, have been previously described (Ernst et al., 1992; Miller et al., 1996) and were generously provided by Dr. Clark L. Anderson. The human ␥ chain cDNA in vector pSVL and monospecific rabbit serum 934 against it have been described (Kuster et al., 1990; Letourneur et al., 1991) and were gifts from Dr. Jean-Pierre Kinet (Harvard University, Cambridge, MA). Mouse monoclonal anti-Fc␥RI antibody 32.2 (Anderson et al., 1986) was obtained from Dr. John Looney (University of Rochester, Rochester, NY). Plasmids were propagated in transformed JM109 strain Escherichia coli and purified using Qiagen affinity columns. The cDNAs were individually or cotransfected into COS-7 cells by the diethylaminoethyl-dextran method (Ernst et al., 1992) as described by Lowry et al. (1998) . In some cotransfection experiments several Fc␥RI:␥ chain ratios (3:6, 3:3, 3:1 g plasmid DNA/100-mm dish) were used. Cells were used 48-72 h after transfection when expression was generally on the order of 20-50% as estimated by indirect immunofluorescence using anti-Fc␥RI or anti-␥ chain antibodies. Phase-contrast and fluorescence microscopy were used as described by Lowry et al. (1998) to measure Fc␥RI expression or coexpression with the ␥ chain subunit by rosetting or phagocytosis of antibody-sensitized FITC-labeled sheep red blood cells, respectively. Rosetting was expressed as the percentage of cells binding three or more SRBC sensitized with a subagglutinating amount of rabbit anti-sheep erythrocyte antiserum. The phagocytic index was defined as the number of SRBC internalized by 100 Fc␥RI-expressing COS cells.
Dengue 2 virus immune complexes and COS cell plaque assay
Convalescent anti-dengue virus sera from Thai and Puerto Rican dengue fever patients were generously provided by Drs. Eric Henchal (Walter Reed Army Institute of Research, Washington, DC) and Gladys Sather (Centers for Disease Control, Puerto Rico), respectively: a single antiserum pool that neutralized dengue 2 virus was used with C6/36 mosquito cell-passaged New Guinea C strain dengue 2 virus (pool titer: ca. 1 ϫ 10 8 PFU/ml) to prepare antibody-virus complexes. These were formed by incubating 1-5 ϫ 10 6 PFU virus with antiserum for 90 min at 37°C: antiserum diluted ca. 1/1000 to 1/5000 gave maximally enhanced virus plaque formation in Fc␥RI-transfected COS cells. Immune complexes were added to trypsinized COS cells in suspension [Fc␥RI is trypsin-resistant (Anderson and Abraham, 1980) ] and the mixture was immediately transferred to 60-mm dishes or tissue culture cluster plates, 1 ϫ 10 6 cells/60-mm dish, proportionately fewer for smaller for-mats. These were incubated overnight to allow monolayer formation before agarose overlay. Neutral red-containing agarose was added 4 days after infection and plaques were photographed with Kodak LPD4 Precision Line high-contrast, high-resolution transparency film for counting by projection onto a screen. Data were analyzed for statistical significance using Student's t test.
Fc␥RI blockade by myeloma proteins
Highly purified human IgG1 and IgG2 myeloma proteins were gifts from Dr. George Abraham (University of Rochester, Rochester, NY). Myeloma proteins or control human serum albumin were mixed with immune complex solutions before incubation with trypsinized control or transfected COS cells.
